Back
Zevra Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
ZVRA
Zevra Therapeutics
Last Price:
8.06
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight selling pressure.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.76 | Buy |
| 20-day SMA: | 7.47 | Buy |
| 50-day SMA: | 7.01 | Buy |
| 200-day SMA: | 5.77 | Buy |
| 8-day EMA: | 7.78 | Buy |
| 20-day EMA: | 7.52 | Buy |
| 50-day EMA: | 6.95 | Buy |
| 200-day EMA: | 5.9 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 64.18 | Buy |
| Chaikin Money Flow: | -1240392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.17 - 7.73) | Buy |
| Bollinger Bands (100): | (4.65 - 7.11) | Buy |
Zevra Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 8.06 while ZVRA 8-day simple moving average is 7.76, which is a Buy signal.
- The stock price of ZVRA is 8.06 while Zevra Therapeutics 20-day SMA is 7.47, which makes it a Buy.
- Zevra Therapeutics 50-day simple moving average is 7.01 while ZVRA share price is 8.06, making it a Buy technically.
- ZVRA stock price is 8.06 and Zevra Therapeutics 200-day simple moving average is 5.77, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a Buy
The current Zevra Therapeutics [ZVRA] share price is $8.06. The Score for ZVRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
424.1M
Price in USD:
8.06
Share Volume:
5.07M
Zevra Therapeutics 52-Week Range
52-Week High:
8.95
52-Week Low:
3.89
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?
The Zevra Therapeutics stock price is 8.06 USD today. -
Will ZVRA stock go up or go down?
Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Zevra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 8.06 while ZVRA 8-day exponential moving average is 7.78, which is a Buy signal.
- The stock price of ZVRA is 8.06 while Zevra Therapeutics 20-day EMA is 7.52, which makes it a Buy.
- Zevra Therapeutics 50-day exponential moving average is 6.95 while ZVRA share price is 8.06, making it a Buy technically.
- ZVRA stock price is 8.06 and Zevra Therapeutics 200-day simple moving average is 5.90, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.32 per share, and an increase next year of $0.99 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
- ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Zevra Therapeutics is a Buy
- Zevra Therapeutics Relative Strength Index (RSI) is 64.18, which suggest Zevra Therapeutics is overbought
- The Bollinger Bands (25) for Zevra Therapeutics is (7.17 - 7.73), which suggest Zevra Therapeutics is a Buy
- The Bollinger Bands (100) for Zevra Therapeutics is (4.65 - 7.11), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.